Michael Thomas Henderson sold $1.5M of Apogee Therapeutics (APGE)

Executed Mar 11, disclosed Mar 13, 2 days later.

Value, as filed

$1.5M

20,000 sh across 3 lots

Executed

Mar 11

the trade date, as filed

Disclosed

Mar 13

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Michael Thomas Henderson Director profile →

Michael Thomas Henderson (Director) filed 13 Form 4 reports in the trailing twelve months (0 purchases, 13 sales), most often in Apogee Therapeutics, Inc. (APGE). The largest single filing was $10.6M of APGE (80,000 sh × $132.54, as filed), executed Jun 22.

The name

APGE

Apogee Therapeutics, Inc. APGE · Healthcare · 47 filings in 24 months ticker →

Healthcare · Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma,…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Michael Thomas Henderson in APGE

APGESALE Apogee Therapeutics, Inc. $2.7M
20,000 sh × $133.63
Exec Jul 8
Filed Jul 10 · 8:00 PM ET APGESALE Apogee Therapeutics, Inc. $10.6M
80,000 sh × $132.54
Exec Jun 22
Filed Jun 24 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. $1.5M
18,306 sh across 4 lots
Exec Jun 10
Filed Jun 12 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. $1.6M
20,000 sh across 2 lots
Exec May 13
Filed May 15 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. $1.6M
19,800 sh across 2 lots
Exec Apr 8
Filed Apr 10 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. $1.2M
19,045 sh across 2 lots
Exec Feb 11
Filed Feb 13 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. $1.6M
19,530 sh across 5 lots
Exec Jan 14
Filed Jan 16 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. $1.5M
19,440 sh across 2 lots
Exec Dec 10 2025
Filed Dec 12 2025 · 5:30 PM ET